Skip to main content

emtricitabine/tenofovir alafenamide fumarate (Descovy®)


Appraisal in progress


Status: In progress

Pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection in at‑risk men who have sex with men, including adolescents (with body weight at least 35 kg).

Medicine details

Medicine name emtricitabine/tenofovir alafenamide fumarate (Descovy®)
Formulation 200 mg/25 mg film-coated tablet
Reference number 2566

as above

Company Gilead Sciences Ltd
BNF chapter Infections
Submission type Directed
Status In progress
NMG meeting date 07/06/2023
AWMSG meeting date 11/07/2023
Date of issue TBC
Follow AWTTC: